PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.
about
Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab.PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.Nivolumab for the Treatment of Classical Hodgkin Lymphoma.
P2860
PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
PD-1 blockade induces remissio ...... tic stem cell transplantation.
@en
type
label
PD-1 blockade induces remissio ...... tic stem cell transplantation.
@en
prefLabel
PD-1 blockade induces remissio ...... tic stem cell transplantation.
@en
P2093
P2860
P1476
PD-1 blockade induces remissio ...... tic stem cell transplantation.
@en
P2093
Elizabeth Hyjek
James Godfrey
Justin Kline
Michael R Bishop
P2860
P2888
P356
10.1186/S40425-017-0211-Z
P577
2017-02-21T00:00:00Z
P6179
1083644033